John Neis, Director at Cellectar Biosciences, Inc. (CLRB), bought 469,484 shares at $2.12 ($995K) on 2016-04-20, disclosed to the SEC on 2016-04-21.
Open-market purchase of $995k CLRB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.12 | 234,742 | $498K | 50.0% |
| 2 | $2.12 | 234,742 | $498K | 50.0% |
| Total | $2.12 avg | 469,484 | $995K | 100% |
| Filing → |
| CLRB | BUY | 2016-11-30 | $993K | — | Filing → |
| CLRB | BUY | 2014-08-22 | $1.0M | — | Filing → |
| TTPY | SELL | 2007-10-18 | $14.1M | — | Filing → |